• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL2000002 重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白注射液 Injection Biological Products(13) New Drug Application 2020-01-08 四川三叶草生物制药有限公司 Sichuan Clover Biopharmaceuticals Co Ltd In Review 2020-01-07 view
CYSB2400234 重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白注射液 Injection Biological Products(3.4) Supplementary Application 2024-09-11 Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd view
CXSL1500119 重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白注射液 Injection Biological Products(13) New Drug Application 2016-03-11 四川三叶草生物制药有限公司 Sichuan Clover Biopharmaceuticals Co Ltd Certificate Issued 2017-12-21 view
CXSL1100026 重组人II型肿瘤坏死因子受体-抗体融合蛋白注射液 Injection Biological Products(13) New Drug Application 2011-07-20 上海中信国健药业股份有限公司 Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd Certificate Issued 2013-07-19 view
CXSS2300056 重组人II型肿瘤坏死因子受体-抗体融合蛋白注射液 Injection Biological Products(3.4) New Drug Application 2023-07-22 Hisun Biopharmaceutical Co Ltd view
CXSL2000191 重组人II型肿瘤坏死因子受体-抗体融合蛋白注射液 Injection Biological Products(13) New Drug Application 2020-07-04 海正生物制药有限公司 Hisun Biopharmaceutical Co Ltd In Review 2020-07-03 view
CXSS2101018 重组人II型肿瘤坏死因子受体-抗体融合蛋白注射液 Injection Biological Products(3.4) New Drug Application 2021-08-03 Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd view
CXSS2101017 重组人II型肿瘤坏死因子受体-抗体融合蛋白注射液 Injection Biological Products(3.4) New Drug Application 2021-08-03 Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd view
CXSS1900033 重组人II型肿瘤坏死因子受体-抗体融合蛋白注射液 Injection Biological Products(13) New Drug Application 2019-08-06 三生国健药业(上海)股份有限公司 Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd Certificate Issued 2021-07-05 view
CXSS2300055 重组人II型肿瘤坏死因子受体-抗体融合蛋白注射液 Injection Biological Products(3.4) New Drug Application 2023-07-22 Hisun Biopharmaceutical Co Ltd view
CXSS2101013 重组人II型肿瘤坏死因子受体-抗体融合蛋白注射液 Injection Biological Products(3.4) New Drug Application 2021-08-03 Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd view